Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United KingdomDecember 9th, 2021
FiledDecember 9th, 2021BURLINGTON, Ontario--(BUSINESS WIRE)--December 9, 2021--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland Health Limited (“Oakland Health” operating as “RD Therapeutics”) to supply QuickStrip™ products to the United Kingdom and the European Union.